Search research articles
Contact Us
Filters
Showing results (201-210 of 329) with videos related to
Page
of 33
Sort By:
The Journal of Antimicrobial Chemotherapy
|
May 27, 2014
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes
Michela Pollicita, Matteo Surdo, Fabiola Di Santo, et al.
Plos One
|
January 26, 2013
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes
Charlotte Charpentier, Sidonie Lambert-Niclot, Claudia Alteri, et al.
Life (Basel, Switzerland)
|
December 23, 2022
SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
Stephane Marot, Djeneba Bocar Fofana, Philippe Flandre, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 2008
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro
Isabelle Malet, Olivier Delelis, Marc-Antoine Valantin, et al.
Haematologica
|
September 21, 2004
High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease
Jean Gabarre, Anne-Geneviève Marcelin, Nabih Azar, et al.
Plos One
|
December 1, 2016
TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains
Coralie Lheure, Philippe Alain Grange, Guillaume Ollagnier, et al.
The Journal of Antimicrobial Chemotherapy
|
April 9, 2014
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors
Isabelle Malet, Laura Gimferrer Arriaga, Anna Artese, et al.
The Journal of Antimicrobial Chemotherapy
|
July 6, 2012
Risk factors for raltegravir resistance development in clinical practice
Isabelle Malet, Slim Fourati, Laurence Morand-Joubert, et al.
British Journal of Haematology
|
February 20, 2025
Longitudinal analysis of lentiviral and retroviral chimeric antigen receptors' integration sites reveals distinct clonal evolutionary patterns
Vincent Guiraud, Jerome Alexandre Denis, Ghizlane Benhafoun, et al.
Plos One
|
October 8, 2013
A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity
David W Wright, Ilona P Deuzing, Philippe Flandre, et al.
Page
of 33
Search research articles
Search
Showing results (201-210 of 329) with videos related to
Sort By:
Page
of 33
The Journal of Antimicrobial Chemotherapy
|
May 27, 2014
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes
Michela Pollicita, Matteo Surdo, Fabiola Di Santo, et al.
Plos One
|
January 26, 2013
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes
Charlotte Charpentier, Sidonie Lambert-Niclot, Claudia Alteri, et al.
Life (Basel, Switzerland)
|
December 23, 2022
SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
Stephane Marot, Djeneba Bocar Fofana, Philippe Flandre, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 2008
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro
Isabelle Malet, Olivier Delelis, Marc-Antoine Valantin, et al.
Haematologica
|
September 21, 2004
High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease
Jean Gabarre, Anne-Geneviève Marcelin, Nabih Azar, et al.
Plos One
|
December 1, 2016
TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains
Coralie Lheure, Philippe Alain Grange, Guillaume Ollagnier, et al.
The Journal of Antimicrobial Chemotherapy
|
April 9, 2014
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors
Isabelle Malet, Laura Gimferrer Arriaga, Anna Artese, et al.
The Journal of Antimicrobial Chemotherapy
|
July 6, 2012
Risk factors for raltegravir resistance development in clinical practice
Isabelle Malet, Slim Fourati, Laurence Morand-Joubert, et al.
British Journal of Haematology
|
February 20, 2025
Longitudinal analysis of lentiviral and retroviral chimeric antigen receptors' integration sites reveals distinct clonal evolutionary patterns
Vincent Guiraud, Jerome Alexandre Denis, Ghizlane Benhafoun, et al.
Plos One
|
October 8, 2013
A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity
David W Wright, Ilona P Deuzing, Philippe Flandre, et al.
Page
of 33